Axon Enterprise, Inc $AXON Shares Bought by Handelsbanken Fonder AB

Handelsbanken Fonder AB grew its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 9.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 65,590 shares of the biotechnology company’s stock after buying an additional 5,423 shares during the quarter. Handelsbanken Fonder AB’s holdings in Axon Enterprise were worth $47,070,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. Stone House Investment Management LLC purchased a new position in Axon Enterprise in the third quarter worth $29,000. New Millennium Group LLC purchased a new stake in Axon Enterprise during the third quarter worth $29,000. Root Financial Partners LLC acquired a new stake in Axon Enterprise in the 3rd quarter valued at about $34,000. Darwin Wealth Management LLC purchased a new position in Axon Enterprise during the 2nd quarter valued at about $37,000. Finally, NewSquare Capital LLC increased its holdings in Axon Enterprise by 96.2% during the 2nd quarter. NewSquare Capital LLC now owns 51 shares of the biotechnology company’s stock valued at $42,000 after acquiring an additional 25 shares in the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Key Axon Enterprise News

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Q4 beat and bullish bookings — Axon reported a double beat (EPS and revenue), ~39% revenue growth and a material increase in future contracted bookings with raised multi‑year sales targets, which triggered the stock rally. Read More.
• Positive Sentiment: AI narrative driving subscription demand — Coverage highlights that Axon’s AI features (body‑camera analytics, Draft One report drafting, evidence management) are accelerating software adoption and upsells, supporting revenue visibility beyond hardware. Read More.
• Neutral Sentiment: Analysts recalibrating models — Several firms trimmed price targets after the print (Piper Sandler, others); many maintained buy/overweight stances, so these moves reflect model updates and volatility rather than a wholesale negative verdict. Read More.
• Neutral Sentiment: Short‑interest data flagged as anomalous — Recent short‑interest reports show zero/NaN figures (likely a reporting anomaly); nothing actionable from that data point for now.
• Negative Sentiment: Some analysts flag downside risk — Morgan Stanley and UBS issued more cautious outlooks/pessimistic scenarios that could cap upside if execution or margins slip. Read More. | Read More.
• Negative Sentiment: Profitability and margin recovery remain a watch item — Commentators note fast revenue growth but slower profit improvement and the need for FCF conversion; sustained margin progress is required to justify high multiples. Read More.
• Negative Sentiment: Insider sale disclosed — CEO Patrick Smith sold 10,000 shares (~$5.0M) on Feb. 25; small relative to his holdings but notable to traders monitoring insider activity. Read More.

Wall Street Analyst Weigh In

Several analysts have recently commented on AXON shares. Robert W. Baird set a $800.00 price target on shares of Axon Enterprise in a research report on Wednesday. Northcoast Research upgraded Axon Enterprise from a “neutral” rating to a “buy” rating and set a $742.00 target price on the stock in a report on Tuesday, January 6th. Piper Sandler cut their price target on Axon Enterprise from $753.00 to $690.00 and set an “overweight” rating for the company in a report on Wednesday. Citigroup restated a “buy” rating on shares of Axon Enterprise in a research report on Wednesday. Finally, Needham & Company LLC dropped their price objective on Axon Enterprise from $870.00 to $600.00 and set a “buy” rating for the company in a research report on Friday, February 20th. Sixteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $762.93.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, CFO Brittany Bagley sold 2,000 shares of the business’s stock in a transaction dated Thursday, December 11th. The stock was sold at an average price of $580.00, for a total transaction of $1,160,000.00. Following the completion of the sale, the chief financial officer owned 103,501 shares of the company’s stock, valued at approximately $60,030,580. The trade was a 1.90% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Jennifer H. Mak sold 1,134 shares of the firm’s stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $600.00, for a total value of $680,400.00. Following the completion of the transaction, the chief accounting officer owned 13,740 shares in the company, valued at approximately $8,244,000. This trade represents a 7.62% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 58,040 shares of company stock worth $32,251,738. 4.40% of the stock is currently owned by company insiders.

Axon Enterprise Trading Down 1.4%

NASDAQ AXON opened at $542.40 on Friday. The company has a market cap of $43.61 billion, a P/E ratio of 356.84, a P/E/G ratio of 16.57 and a beta of 1.48. Axon Enterprise, Inc has a 12 month low of $396.41 and a 12 month high of $885.91. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.53 and a quick ratio of 2.89. The company has a 50-day moving average of $537.92 and a 200-day moving average of $625.54.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.60 by $0.55. Axon Enterprise had a net margin of 4.48% and a return on equity of 2.82%. The firm had revenue of $796.72 million during the quarter, compared to the consensus estimate of $755.29 million. During the same period in the previous year, the firm earned $2.08 earnings per share. Axon Enterprise’s revenue was up 38.5% compared to the same quarter last year. As a group, equities analysts predict that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.